OBJECTIVE: Although professional organizations have recommended prenatal screening for conditions like cystic fibrosis and Down syndrome for years, the adoption of expanded carrier screening (ECS) and non-invasive prenatal screening (NIPS) have increased the scope of information available to patients and providers alike. These advances have in turn increased the number of patients needing timely results delivery alongside appropriate counseling, management, and follow-up care. Here, we describe an automated system that utilizes online education and tele-genetic counseling to aid health professionals in delivering genetic testing results in an effective and timely manner. STUDY DESIGN: Providers were notified upon availability of patient results. For ECS results indicating a high reproductive risk, patients received an auto-generated email directing them to schedule a consultation with a laboratory genetic counselor. Screen-positive NIPS results were delivered to the ordering provider, who could request that a laboratory genetic counselor contact the patient. All other results could be viewed directly by the patient in an online portal and were accompanied by written and video resources. Regardless of result type, patients had the option to speak to a genetic counselor, either on-demand or by scheduling an appointment. RESULTS: Through December 2017, 278,318 ECS results and 67,122 NIPS results were issued via the system. Of these, 41,050 (15%) ECS patients and 4,673 (7%) NIPS patients elected genetic counseling, with some electing multiple consultations, resulting in a total of 47,793 consultations. A substantial number of patients electing genetic counseling received negative results (w50% ECS, 95% NIPS). Patients also frequently utilized on-demand services (32% ECS, 70% NIPS). Median consultation duration times were ten minutes and nine minutes for ECS and NIPS results, respectively. CONCLUSION: We describe a system that can provide large-scale prenatal genetic testing results delivery, education, and counseling congruent with clinical guidelines. Such services are imperative to quality clinical care as genetic testing uptake grows among the general obstetric population and additional high risk pregnancies needing follow-up management are identified.
877 Rare adds up: Characterization of mosaicism in rare autosomal aneuploidies via noninvasive prenatal screening Albert Lee, Susan Hancock, Carrie Haverty, Kevin R. Haas Myriad Women's Health, South San Francisco, CA OBJECTIVE: Reports of rare autosomal aneuploidy (RAA) from noninvasive prenatal screening (NIPS) via whole-genome sequencing (WGS) have important clinical implications due to placental mosaicism, uniparental disomy (UPD), and true fetal aneuploidy. We explored the prevalence of RAA and relative degree of mosaicism (DOM) detected via NIPS for RAA versus for common aneuploidies (13, 18, 21) and the effect on results interpretation. STUDY DESIGN: To characterize prevalence and the degree of mosaicism in all aneuploidies, a retrospective analysis of 48,965 sequential prenatal NIPS samples processed via WGS was performed. Aneuploidy was identified using a z-score that reflected the significance of enrichment or depletion in WGS read density. For the purposes of this study, we examined high confidence positives defined as having jzj > 6. DOM is defined as the ratio of the fetal fraction estimated from WGS read-density enrichment on the positive chromosome (FF_pos) to the orthogonal, regression-based fetal fraction measurement inferred from the collection of read density values across all autosomes (FF_inferred). DOM less than 0.5 was chosen for the threshold at which a positive RAA call was qualified as being mosaic. RESULTS: 266 out of 48,965 samples (0.5%) had an RAA. The most common RAAs occurred in chromosomes 7, 8, 15, 16, and 20 . Near zero prevalences of RAAs on chromosomes 1, 11, 17, and 19 are consistent with previous reports. We showed that the frequency of mosaicism differed between common aneuploidies and RAAs; 4.44% of samples positive for chromosome 21 were estimated to have DOM less than 0.5. In contrast, for chromosome 7, 87.69% of positive samples were estimated to have DOM less than 0.5. CONCLUSION: Our findings suggest that mosaicism may be common-not an edge case-in RAA and, therefore, must be taken into account when reporting positives. Accurate screen-positive calls for RAA and common aneuploidy therefore uniquely depend on established laboratory criteria for DOM. Interpreting these results in the same manner as those for common aneuploidies may otherwise compromise the clinical value of screening for RAA due to potential false negatives. OBJECTIVE: Prenatal chromosomal microarray (CMA) is recommend by SMFM for fetuses with ultrasound anomalies. A limitation of CMA is findings of variants of uncertain significance (VUS). Our objective was to determine how many VUSs were associated with a well-known phenotype, and in each, the level of likelihood of an affected phenotype, with the ultimate goal to establish how many VUSs are truly uncertain. STUDY DESIGN: All patients who had prenatal CMA with a VUS reported at our center since 2014 were included. We categorized variants as: variable penetrance; a rare copy number variant (CNV) that includes a gene with a known phenotype; likely autosomal recessive (AR) carrier status; CNV size >1 Mb without disease-causing genes; mosaicism; and region (s) of homozygosity (ROH) >5 Mb or >3% of the genome. For each category, we considered whether the potential phenotype(s) associated with the VUS was known or uncertain. VUSs with variable penetrance, AR carrier status and mosaicism were considered to be associated with a well-described phenotype, while the others were not. We also determined the level of certainty regarding the likelihood of an affected phenotype, which determines our confidence in the information we could provide to the patient regarding the prognosis. VUSs with variable penetrance, AR carrier status, mosaicism and size >1Mb had a known likelihood of having a disease, so were considered to have high certainty in counseling. VUSs due to ROH are known to have a higher risk of
